Filing Details
- Accession Number:
- 0000899243-19-024658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-02 16:08:49
- Reporting Period:
- 2019-10-01
- Accepted Time:
- 2019-10-02 16:08:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661998 | Homology Medicines Inc. | FIXX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1317678 | Bradford W Smith | C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730 | Cfo, Treasurer & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-10-01 | 6,000 | $0.64 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-10-01 | 5,900 | $17.38 | 100 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-10-01 | 100 | $18.23 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option | Disposition | 2019-10-01 | 6,000 | $0.00 | 6,000 | $0.64 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 133,404 | 2027-04-05 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2018.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $17.10 to $17.85. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested and became exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 3, 2017.
Billionaire Hedge Funds
